GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Chordia Therapeutics 190A.T · JPY

Health Care · Tokyo Stock Exchange · 🇯🇵 Japan

Compare

44

+4.76%

Close of 9 Nov 2026, in JPY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in JPY, from our data supplier.

FY2026

Revenue

—

FY2021FY2026

Net income

−¥1.46bn

FY2021FY2026

Free cash flow

−¥1.42bn

FY2021FY2026

Shareholders' equity

¥1.93bn

FY2021FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021
Revenue———¥2.50bn—¥800.0m
Gross profit—−¥1.43bn−¥4.1m¥2.49bn−¥3.1m¥800.0m
Research and development¥1.15bn¥1.43bn¥1.50bn¥2.00bn¥1.66bn¥1.22bn
Operating income−¥1.47bn−¥1.79bn−¥1.80bn¥212.1m−¥1.84bn−¥587.7m
Net income−¥1.46bn−¥1.79bn−¥1.83bn¥223.3m−¥1.78bn−¥527.1m
Diluted earnings per share-18.90-25.64-26.873.96-23.11-6.85

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021
Total assets¥2.11bn¥2.68bn¥4.63bn¥4.91bn¥4.50bn¥2.27bn
Cash and short-term investments¥2.05bn¥2.55bn¥4.33bn¥4.80bn¥4.25bn¥2.00bn
Total liabilities¥188.8m¥244.3m¥471.1m¥408.2m¥221.4m¥214.9m
Shareholders' equity¥1.93bn¥2.44bn¥4.16bn¥4.50bn¥4.28bn¥2.06bn
Shares outstanding77m70m68m56m77m77m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021
Cash from operations−¥1.42bn−¥1.84bn−¥1.94bn¥543.7m−¥1.70bn−¥544.6m
Capital spending−¥2.6m−¥5.3m−¥537,000−¥723,000−¥13.5m−¥2.3m
Free cash flow−¥1.42bn−¥1.84bn−¥1.94bn¥543.0m−¥1.72bn−¥546.9m

Latest quarters

By quarter end

Aug 2026May 2026Feb 2026Nov 2025Aug 2025May 2025Feb 2025Nov 2024
Gross profit————−¥797,000−¥682,000−¥434,000−¥789,000
Operating income−¥403.1m−¥408.0m−¥356.5m−¥306.3m−¥368.9m−¥424.5m−¥372.0m−¥624.4m
Net income−¥407.5m−¥414.0m−¥338.4m−¥295.3m−¥386.5m−¥423.0m−¥359.9m−¥616.4m
Diluted earnings per share-5.29-5.38-4.40-4.24-5.55-6.07-5.17-9.07
Cash from operations————−¥1.84bn———
Capital spending————−¥5.0m———
Free cash flow————−¥1.84bn———
Total assets¥2.11bn¥2.59bn¥2.51bn¥2.48bn¥2.68bn¥2.99bn¥3.45bn¥3.78bn
Cash and short-term investments¥2.05bn¥2.51bn¥2.45bn¥2.34bn¥2.55bn¥2.82bn¥3.28bn¥3.44bn
Shareholders' equity¥1.93bn¥2.33bn¥2.32bn¥2.30bn¥2.44bn¥2.82bn¥3.25bn¥3.57bn

Growth per year

Compound annual rate

3 years5 years10 years
Operating income—20.2%—
Net income—22.5%—

Valuation history

At each fiscal year end

FY2026FY2025FY2024
Price to earnings-2.5-4.2-11.8

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.